Foot Locker beats earnings expectations but expects lower profits due to promotional pressures from Nike
From CNBC: 2025-03-05 06:48:29 Foot Locker anticipates another year of widespread discounts in the sneaker industry due to Nike’s reset
Category: Earnings
THOR Industries reports decrease in net sales, gross profit margin, and net loss
From GlobeNewswire: 2025-03-05 06:30:00 THOR Industries, Inc. reported fiscal 2025 second-quarter results with net sales at $2.02 billion, down 8.6%
Adidas exceeded sales expectations in Q4 2024, with positive forecasts for 2025.
From CNBC: 2025-03-05 03:10:49 Adidas exceeded fourth-quarter sales expectations with a 19% increase to 5.97 billion euros and an operating
CrowdStrike exceeded expectations in Q4, but falls slightly short for fiscal 2026 guidance
From CNBC: 2025-03-04 19:34:00 CrowdStrike exceeded expectations in Q4 with revenue, adjusted earnings, and net new annual recurring revenue. Fiscal
CrowdStrike shares dropped 9% in after-hours trading as company's earnings guidance disappointed
From CNBC: 2025-03-04 18:23:07 CrowdStrike shares fell nearly 9% in after-hours trading due to disappointing earnings guidance. The company reported
Earnings reports indicate mixed results with some companies showing increases and others decreases
From Nasdaq.: 2025-03-04 16:00:00 Earnings reports for various companies are expected on 03/05/2025. Campbell’s Company (CPB) is forecasted to have
Okta's shares surged 22% after strong Q4 earnings, beating estimates and showing high growth potential.
From CNBC: 2025-03-04 14:42:59 Okta Inc. CEO Todd McKinnon was all smiles as the company’s shares surged 22% following strong
Earnings reports for multiple companies project decreases in earnings per share
From Nasdaq: 2025-03-04 14:00:01 After hours on 03/04/2025, CrowdStrike Holdings, Inc. (CRWD) is expected to report earnings for the quarter
Adial Pharmaceuticals achieves key milestones for drug AD04, secures FDA approval and new patents.
From GlobeNewswire: 2025-03-04 08:30:00 Adial Pharmaceuticals, Inc. reported successful completion of a key pharmacokinetics study for AD04, confirming bioavailability and
Best Buy exceeds earnings expectations in Q4 2025 but projects price increases due to tariffs.
From CNBC: 2025-03-04 08:23:00 Best Buy exceeded expectations in fourth-quarter earnings and revenue but projects price increases for U.S. consumers
L.B. Foster Company reports profitability in 2024, authorizes new stock repurchase program
From GlobeNewswire: 2025-03-04 08:00:00 L.B. Foster Company reported improved gross margins in the fourth quarter and full year of 2024,
AutoZone's second-quarter sales increased by 2.4%, with strategy to expand into international markets
From GlobeNewswire: 2025-03-04 06:55:00 AutoZone reported net sales of $4.0 billion for the second quarter ended February 15, 2025, up
Olaplex reports decrease in net sales and income, plans investments for fiscal year 2025
From GlobeNewswire: 2025-03-04 06:45:00 Olaplex Holdings, Inc. (NASDAQ: OLPX) reported financial results for Q4 and fiscal year 2024. Net sales
Y-mAbs reported increased revenues for Q4 2024 and full year, with upcoming conference call.
From GlobeNewswire: 2025-03-04 06:35:00 Y-mAbs Therapeutics, Inc. reported revenues of $26.5 million for Q4 2024 and $87.7 million for the
Target reports Q4 earnings with raised sales guidance but struggles with discretionary merchandise
From CNBC: 2025-03-04 00:01:02 Target will report fiscal fourth-quarter earnings, with analysts expecting earnings per share of $2.26 and revenue
Dave Inc. saw strong revenue and net income growth in Q4 and full year 2024.
From GlobeNewswire: 2025-03-03 16:05:00 Dave Inc. reported a 38% increase in Q4 revenue to $100.9 million and a 34% increase
Mixed earnings reports expected for various companies on March 4, 2025.
From Nasdaq: 2025-03-03 16:00:01 Multiple companies are set to report earnings on 03/04/2025. Plug Power, Inc. (PLUG) expects a $-0.23
Major U.S. equity indices closed lower in February due to growth/stagflation concerns
From Nasdaq: 2025-03-03 16:00:00 In February, all major U.S. equity indices closed lower due to growth/stagflation concerns. 10 of 11
Mixed earnings with some companies showing decreases and some showing increases
From Nasdaq: 2025-03-03 14:00:00 Okta, Inc. (OKTA) is expected to report earnings with a forecast of $0.16 per share, a
Market downturn affecting Bitcoin and Coinbase, but MARA, CORZ, CIFR, and BTDR show potential growth
From Nasdaq: 2025-03-03 08:33:00 The cryptocurrency market, including Bitcoin and Coinbase Global (NASDAQ: COIN), is experiencing a sell-off with Bitcoin
California Resources Corporation reported strong financial results for Q4 2024 and FY 2024 with positive outlook for 2025.
From GlobeNewswire: 2025-03-03 08:32:00 California Resources Corporation (CRC) reported financial and operating results for Q4 2024 and FY 2024, with
Annexon reports strong financial performance in Q4 2024, advancing promising therapies in pipeline.
From GlobeNewswire: 2025-03-03 08:00:00 Annexon, Inc. reports robust Phase 3 data and real-world evidence supporting ANX005 as a potential first
Monroe Capital Corporation reported solid financial results for Q4 2024 and full year 2024.
From GlobeNewswire: 2025-03-03 07:35:00 Monroe Capital Corporation (NASDAQ: MRCC) announced its financial results for Q4 2024, with net investment income
TG Therapeutics reports strong BRIUMVI revenue and pipeline developments, aiming for $540 million total revenue in 2025.
From GlobeNewswire: 2025-03-03 07:00:00 TG Therapeutics, Inc. reported 2024 BRIUMVI U.S. net revenue of $103.6 million for the fourth quarter
ArriVent BioPharma shows strong clinical data for firmonertinib, expands ADC portfolio, reports financial loss.
From GlobeNewswire: 2025-03-03 07:00:00 ArriVent BioPharma reported strong clinical data for firmonertinib in first-line NSCLC EGFR PACC mutations. Achieved target